Built on our patented platforms

Every product in the SysGene portfolio has been designed, developed and manufactured using SysGene’s patented bacterial secretion and mammalian expression platforms, the same platforms offered for development, licensing and technology-transfer programs.

See the platforms and the evidence behind them→

Intended use

Nucleic acid reduction in bioprocessing

DRNase product vial

Process integration

Confirmed for your process

  • Addition point

    Confirmed against the specific unit operation.

  • Contact time

    Set to achieve the required nucleic-acid reduction.

  • Removal strategy

    Defined alongside the downstream train.

  • Downstream compatibility

    Assessed against chromatography and polishing steps.

Discuss your nucleic acid removal process

Share the process step and target reduction and we will respond with the relevant technical and commercial information.

Discuss Your Nucleic Acid Removal Process